{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:51:14Z","timestamp":1786200674132,"version":"build-2736575974"},"reference-count":129,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103741","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:23:48Z","timestamp":1760030628000},"page":"103741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel AMP-activated protein kinase activators and their potential for mitigating renal injury and fibrosis"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6992-5392","authenticated-orcid":false,"given":"Geoff","family":"Harley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7637-3661","authenticated-orcid":false,"given":"Peter F.","family":"Mount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103741_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.kint.2017.07.030","article-title":"Cellular and molecular pathways of renal repair after acute kidney injury","volume":"93","author":"Kumar","year":"2018","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jpet.2025.103741_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semnephrol.2018.01.003","article-title":"The role of peroxisome proliferator-activator receptor gamma coactivator 1 alpha (PGC-1alpha) in kidney disease","volume":"38","author":"Li","year":"2018","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cm.21809","article-title":"Mapping the cytoskeletal architecture of renal tubules and surrounding peritubular capillaries in the kidney","volume":"81","author":"Kumaran","year":"2024","journal-title":"Cytoskeleton"},{"key":"10.1016\/j.jpet.2025.103741_bib4","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","article-title":"Cellular pathophysiology of ischemic acute kidney injury","volume":"121","author":"Bonventre","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jpet.2025.103741_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ckj\/sfaa177","article-title":"Long-term consequences of acute kidney injury: a narrative review","volume":"14","author":"Gameiro","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jpet.2025.103741_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.kint.2021.03.024","article-title":"Epithelial proliferation and cell cycle dysregulation in kidney injury and disease","volume":"100","author":"Lee","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2403769","article-title":"A randomized trial of intraveneous amino acids for kidney protection","volume":"391","author":"Landoni","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpet.2025.103741_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.kint.2020.09.037","article-title":"Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1alpha","volume":"99","author":"Clark","year":"2021","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jpet.2025.103741_bib9","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1681\/ASN.2018010050","article-title":"Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin","volume":"29","author":"Lee","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib10","article-title":"Metformin protects against cisplatin-induced tubular cell apoptosis and acute kidney injury via AMPKalpha-regulated autophagy induction","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jpet.2025.103741_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tibs.2011.06.004","article-title":"AMP-activated protein kinase: also regulated by ADP?","volume":"36","author":"Hardie","year":"2011","journal-title":"Trends Biochem Sci"},{"issue":"527","key":"10.1016\/j.jpet.2025.103741_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2008.02.011","article-title":"Hypothalamic CaMKK2 contributes to the regulation of energy balance","volume":"7","author":"Anderson","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jpet.2025.103741_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"50","key":"10.1016\/j.jpet.2025.103741_bib15","doi-asserted-by":"crossref","first-page":"35904","DOI":"10.1074\/jbc.M113.508747","article-title":"Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK)","volume":"288","author":"Wu","year":"2013","journal-title":"J Biol Chem"},{"issue":"34","key":"10.1016\/j.jpet.2025.103741_bib16","doi-asserted-by":"crossref","first-page":"30778","DOI":"10.1074\/jbc.M205213200","article-title":"The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofucto-2-kinase","volume":"277","author":"Marsin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2025.103741_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/BJ20090613","article-title":"AMPKalpha1 regulates the antioxidant status of vascular endothelial cells","volume":"421","author":"Colombo","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.jpet.2025.103741_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.jpet.2025.103741_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MNH.0000000000000349","article-title":"Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease","volume":"26","author":"Rajani","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jpet.2025.103741_bib20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/2091244a0","article-title":"Substrate-utilization of the human kidney","volume":"209","author":"Nieth","year":"1966","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpet.2025.103741_bib21","first-page":"291","article-title":"Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney","volume":"1182","author":"Gulati","year":"1993","journal-title":"BiochimBiophys Acta"},{"key":"10.1016\/j.jpet.2025.103741_bib22","doi-asserted-by":"crossref","first-page":"F667","DOI":"10.1152\/ajprenal.2000.278.4.F667","article-title":"Etomoxir-induced PPARalpha-modulated enzymes protects during acute renal failure","volume":"278","author":"Portilla","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpet.2025.103741_bib23","doi-asserted-by":"crossref","first-page":"F679","DOI":"10.1152\/ajprenal.00407.2012","article-title":"AMPK couples plasma renin to cellular metabolism by phosphorylation of ACC1","volume":"305","author":"Fraser","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103741_bib24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jpet.2025.103741_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0006-291X(02)00881-1","article-title":"Effects of low-intensity prolonged exercise on PGC-1 mRNA expression in rat epitrochlearis muscle","volume":"296","author":"Terada","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpet.2025.103741_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cr.2010.46","article-title":"Hypoxia induces PGC-1alpha expression and mitochondrial biogenesis in the myocardium of TOF patients","volume":"20","author":"Zhu","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.jpet.2025.103741_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/cns.13114","article-title":"Exercise activates lysosomal function in the brain through AMPK-SIR1-TFEB pathway","volume":"25","author":"Huang","year":"2019","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"10.1016\/j.jpet.2025.103741_bib28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coavtivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jpet.2025.103741_bib31","unstructured":"Kone BC. Brenner and Rector\u2019s The Kidney. Brenner BM, ed. Saunders Elsevier; 2008."},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib32","first-page":"246","article-title":"Glucose metabolism in dog inner medullary collecting ducts","volume":"17","author":"Meury","year":"1994","journal-title":"Ren Physiol Biochem"},{"key":"10.1016\/j.jpet.2025.103741_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1101\/sqb.2011.76.010868","article-title":"Control of glycolysis through regulation of PFK1: old friends and recent additions","volume":"76","author":"Mor","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.jpet.2025.103741_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-018-0749-z","article-title":"Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury","volume":"565","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103741_bib35","article-title":"Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103741_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280792","article-title":"Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney","volume":"18","author":"Harley","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"18","key":"10.1016\/j.jpet.2025.103741_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94716","article-title":"Molecular characterization of the transition from acute to chronic kidney injury following ischaemia\/reperfusion","volume":"2","author":"Liu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpet.2025.103741_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets","volume":"6","author":"Boor","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jpet.2025.103741_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000368932","article-title":"Beneficial effects of AMP-activated protein kinase agonists in kidney ischemia-reperfusion: autophagy and cellular stress markers","volume":"128","author":"Decl\u00e8ves","year":"2014","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1681\/ASN.2011070690","article-title":"Inhhibition of mTOR disrupts autophagic flux in podocytes","volume":"23","author":"Cin\u00e0","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103741_bib43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0272-6386(95)90610-X","article-title":"Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced","volume":"26","author":"Hay","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpet.2025.103741_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2002.00430.x","article-title":"Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies","volume":"62","author":"Rastaldi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib45","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1681\/ASN.2014111138","article-title":"Differential Ly6C expression after renal ischemia-reperfusion identifies unique macrophage populations","volume":"27","author":"Clements","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040158","article-title":"TXNIP regulates peripheral glucose metabolism in humans","volume":"4","author":"Parikh","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jpet.2025.103741_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00125-010-1692-1","article-title":"Ablation of AMP-activated protein kinase a1 and a2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo","volume":"53","author":"Sun","year":"2010","journal-title":"Diabetologia"},{"issue":"17","key":"10.1016\/j.jpet.2025.103741_bib49","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1042\/BCJ20170458","article-title":"Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells","volume":"474","author":"Willows","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.jpet.2025.103741_bib50","first-page":"209","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.jpet.2025.103741_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112325","article-title":"MK8722, an AMPK activator, inhibiting carcinoma proliferation, invasion and migration in human pancreatic cancer cells","volume":"144","author":"Wang","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7150\/thno.83051","article-title":"MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent repogramming of lipid metabolism","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.jpet.2025.103741_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.aah5582","article-title":"Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy","volume":"357","author":"Myers","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jpet.2025.103741_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211568","article-title":"Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver","volume":"14","author":"Muise","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep4.1799","article-title":"Direct AMPK activation corrects NASH in rodents through metabolic effects and direct action on inflammation and fibrogenesis","volume":"6","author":"Gluais-Dagorn","year":"2022","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib56","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2025.103741_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.jpet.2025.103741_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"10.1016\/j.jpet.2025.103741_bib59","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","article-title":"Metformin reduces liver glucose production by inhibition of fructose-1\u20136-bisphosphatase","volume":"24","author":"Hunter","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jpet.2025.103741_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103741_bib61","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jpet.2025.103741_bib62","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jps.20744","article-title":"Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects","volume":"95","author":"Choi","year":"2006","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.jpet.2025.103741_bib63","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/FPC.0b013e3283559b22","article-title":"Metformin pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jpet.2025.103741_bib64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40620-015-0258-1","article-title":"Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions","volume":"29","author":"Langer","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib65","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pds.3432","article-title":"Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control","volume":"22","author":"Hung","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.jpet.2025.103741_bib66","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway","volume":"77","author":"Morales","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lfs.2014.07.034","article-title":"Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity","volume":"114","author":"Huang","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103741_bib68","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/TP.0000000000002864","article-title":"Metformin attenuates cyclosporine A-induced renal fibrosis in rats","volume":"103","author":"Lin","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jpet.2025.103741_bib69","doi-asserted-by":"crossref","first-page":"F727","DOI":"10.1152\/ajprenal.00293.2013","article-title":"Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease","volume":"305","author":"Satriano","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpet.2025.103741_bib70","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3892\/ijmm.2013.1508","article-title":"Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase\/acetyl-CoA carboxylase pathway in mice","volume":"32","author":"Kim","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jpet.2025.103741_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","volume":"94","author":"Neven","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002967.pub3","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"4","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpet.2025.103741_bib73","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpet.2025.103741_bib74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/dme.12017","article-title":"The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database","volume":"30","author":"Kajbaf","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jpet.2025.103741_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jpet.2025.103741_bib76","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpet.2025.103741_bib77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12882-017-0579-5","article-title":"Risk of acute kidney injury and survival in patients treated with metformin","volume":"18","author":"Bell","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jpet.2025.103741_bib78","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0026-0495(93)90284-U","article-title":"The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients","volume":"42","author":"Johnson","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.jpet.2025.103741_bib79","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/bdd.684","article-title":"A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes","volume":"30","author":"Sogame","year":"2009","journal-title":"Biopharm Drug Dispos"},{"issue":"5\u20136","key":"10.1016\/j.jpet.2025.103741_bib80","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/j.1552-4604.1975.tb02367.x","article-title":"Pharmacokinetics of phenformin in man","volume":"15","author":"Alkalay","year":"1975","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpet.2025.103741_bib81","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/cells10051095","article-title":"AICAr, a widely used AMPK activator with important AMPK-independent effects: a systematic review","volume":"10","author":"Vi\u0161nji\u0107","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jpet.2025.103741_bib82","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","article-title":"5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?","volume":"229","author":"Corton","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jpet.2025.103741_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088087","article-title":"Pharmacological AMP kinase activators target the nucleolar organization and control cell proliferation","volume":"9","author":"Kodiha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2025.103741_bib84","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2018.12.159","article-title":"AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK\/STAT\/SOCS pathway","volume":"509","author":"Tsogbadrakh","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpet.2025.103741_bib85","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1476-5381.2012.01895.x","article-title":"AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney","volume":"166","author":"Lempi\u00e4inen","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.jpet.2025.103741_bib86","article-title":"The AMPK agonist AICAR inhibits TGF-beta1 induced activation of kidney myofibroblasts","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpet.2025.103741_bib87","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/BJ20070105","article-title":"AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside","volume":"404","author":"Guigas","year":"2007","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/acsmedchemlett.7b00417","article-title":"Discovery of MK-8722: a systemic, direct pan-activator of AMP-activated protein kinase","volume":"9","author":"Feng","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"10.1016\/j.jpet.2025.103741_bib89","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.chembiol.2014.05.014","article-title":"Mechanism of action of compound-13: an a1-selective small molecule activator of AMPK","volume":"7","author":"Hunter","year":"2014","journal-title":"Chem Biol"},{"issue":"7","key":"10.1016\/j.jpet.2025.103741_bib90","article-title":"Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding","volume":"8","author":"Langendorf","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jpet.2025.103741_bib91","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","article-title":"Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome","volume":"3","author":"Cool","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jpet.2025.103741_bib92","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1038\/ncomms4017","article-title":"Structural basis of AMPK regulation by small molecule activators","volume":"4","author":"Xiao","year":"2013","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jpet.2025.103741_bib93","doi-asserted-by":"crossref","first-page":"C1041","DOI":"10.1152\/ajpcell.00051.2009","article-title":"A-769662 activates AMPK beta1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle","volume":"297","author":"Treebak","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.jpet.2025.103741_bib94","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99114","article-title":"PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients","volume":"3","author":"Steneberg","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpet.2025.103741_bib95","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2017.04.010","article-title":"Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice","volume":"25","author":"Cokorinos","year":"2017","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib96","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s42003-023-05255-6","article-title":"O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving beta-cell function","volume":"6","author":"Norlin","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jpet.2025.103741_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11091","article-title":"AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism","volume":"8","author":"Esquejo","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jpet.2025.103741_bib98","article-title":"AMPK activator O304 protects against kidney aging through promoting energy metabolism and autophagy","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2025.103741_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116730","article-title":"The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury","volume":"175","author":"Katerelos","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2025.103741_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.119.258244","article-title":"PAN-AMPK activation improves renal function in a rat model of progressive diabetic nephropathy","volume":"371","author":"Zhou","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103741_bib101","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2021.10.028","article-title":"Dephosphorylation of AMP-activated protein kinase exacerbates ischemia\/reperfusion-induced acute kidney injury via mitochondrial dysfunction","volume":"101","author":"Ma","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib102","first-page":"889","article-title":"Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study","volume":"6","author":"Cusi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jpet.2025.103741_bib103","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.kint.2023.01.026","article-title":"A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of autosomal dominant polycystic kidney disease","volume":"103","author":"Dagorn","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpet.2025.103741_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109704","article-title":"Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease","volume":"73","author":"Song","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.jpet.2025.103741_bib105","doi-asserted-by":"crossref","first-page":"F731","DOI":"10.1152\/ajprenal.00541.2015","article-title":"Preconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo","volume":"311","author":"Lieberthal","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpet.2025.103741_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.760026","article-title":"Elucidating the activation mechanism of AMPK by direct pan-activator PF-739","volume":"8","author":"Aledavood","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2025.103741_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101259","article-title":"Direct small molecule ADaM-site AMPK activators reveal an AMPKgamma3-independent mechanism for blood glucose lowering","volume":"51","author":"J\u00f8rgensen","year":"2021","journal-title":"Mol Metab"},{"issue":"12","key":"10.1016\/j.jpet.2025.103741_bib108","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diab.30.12.1000","article-title":"The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization","volume":"30","author":"DeFronzo","year":"1981","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jpet.2025.103741_bib109","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s001250050735","article-title":"Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance","volume":"40","author":"Del Prato","year":"1997","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jpet.2025.103741_bib110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000454924","article-title":"Energy metabolism and ageing in the mouse: a mini-review","volume":"63","author":"Azzu","year":"2017","journal-title":"Gerontology"},{"key":"10.1016\/j.jpet.2025.103741_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113377","article-title":"Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin","volume":"153","author":"Harley","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.jpet.2025.103741_bib112","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/jpet.116.237925","article-title":"Selective activation of AMPK beta1-containing isoforms improves kidney function in a rat model of diabetic nephropathy","volume":"361","author":"Salatto","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jpet.2025.103741_bib113","doi-asserted-by":"crossref","first-page":"F1103","DOI":"10.1152\/ajprenal.00458.2004","article-title":"Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177","volume":"289","author":"Mount","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpet.2025.103741_bib114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103741_bib115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/0886022X.2016.1149770","article-title":"Metformin alleviated EMT and fibrosis after renal ischemia-reperfusion injury in rats","volume":"38","author":"Wang","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/j.jpet.2025.103741_bib116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/ijms17020146","article-title":"Metformin prevents renal fibrosis in mice with unilateral ureteral obstruction and inhibits ang II-induced ECM production in renal fibroblasts","volume":"17","author":"Shen","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103741_bib117","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jss.2014.10.009","article-title":"Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation","volume":"194","author":"Escobar","year":"2015","journal-title":"J Surg Res"},{"key":"10.1016\/j.jpet.2025.103741_bib118","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1210\/en.2013-1002","article-title":"Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway","volume":"154","author":"Cao","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpet.2025.103741_bib119","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.12659\/MSM.911714","article-title":"Resveratrol reduces oxidative stress and apoptosis in podocytes via Sir2-related enzymes, sirtuins 1 (SIRT1)\/peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) axis","volume":"25","author":"Zhang","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jpet.2025.103741_bib120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arcmed.2005.05.018","article-title":"Protective effect of nitric oxide pathway in resveratrol renal ischemia-reperfusion injury in rats","volume":"37","author":"Chander","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jpet.2025.103741_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jpet.2025.103741_bib122","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCRESAHA.115.304538","article-title":"AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation","volume":"115","author":"Zordoky","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jpet.2025.103741_bib123","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.RES.0000258446.23525.37","article-title":"AMP-activated protein kinase in the heart: role during health and disease","volume":"100","author":"Arad","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jpet.2025.103741_bib124","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/CIRCRESAHA.114.302364","article-title":"Mutation in the gamma2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage","volume":"114","author":"Kim","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jpet.2025.103741_bib125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cell.2015.01.034","article-title":"Degradation of AMPK by a cancer-specific ubiquitin ligase","volume":"160","author":"Pineda","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jpet.2025.103741_bib126","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.jpet.2025.103741_bib127","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2018.10.005","article-title":"Genetic analysis reveals AMPK is required to support tumor growth in murine Kras-dependent lung cancer models","volume":"29","author":"Eichner","year":"2019","journal-title":"Cell Metab"},{"issue":"28","key":"10.1016\/j.jpet.2025.103741_bib128","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/onc.2014.301","article-title":"Differential effects of AMPK agonists on cell growth and metabolism","volume":"34","author":"Vincent","year":"2015","journal-title":"Oncogene"},{"issue":"40","key":"10.1016\/j.jpet.2025.103741_bib129","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1038\/onc.2016.70","article-title":"AMPK promotes tolerance to Ras pathway inhibition by activating autophagy","volume":"35","author":"Sanduja","year":"2016","journal-title":"Oncogene"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:18:57Z","timestamp":1764058737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":129,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022356525402547"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103741","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel AMP-activated protein kinase activators and their potential for mitigating renal injury and fibrosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103741"}}